title: [Incidence of encapsulated bleb after filtering surgery].
abstract: OBJECTIVE
  To determine the incidence of encapsulated bleb (EB) after filtering surgery, and the risk factors for the development of this complication, especially those related with the surgical procedure.
  
  
  METHODS
  Ninety eyes that were submitted to trabeculectomy were prospectively studied. Lens extraction was associated in 56 eyes (62.9%). All patients were followed up for at least 3 months.
  
  
  RESULTS
  There were clinical characteristics of encapsulation in 29 eyes (32.3%) and EB with a peak IOP of 25 mmHg or higher in 14 eyes (15.7%). The incidence of EB formation was 20.5% in men and 11.8% in women (p.044). The incidence of EB was higher in the trabeculectomy group alone (24.2%) than in the group in which it was associated to cataract surgery (10.5%) (p.003). There were clinical characteristics of encapsulation in 40.7% of primary open angle glaucoma (p.041). EB was significantly associated with an increased failure rate (21.4%) when compared to normal blebs (5.55% failure rate) (p<.001).
  
  
  CONCLUSIONS
  The encapsulated bleb is significantly more frequent in the male gender and thick conjunctivas and in trabeculectomy alone versus trabeculectomy associated to cataract surgery. It means a significantly greater risk of failure after surgery in the short term.
authors.affiliation: Servicio de Oftalmología, Hospital 12 de Octubre, Madrid, España. egutierrez@hdoc.insalud.es
authors.forename: E
authors.initials: E
authors.lastname: Gutiérrez Díaz
authors.forename: M
authors.initials: M
authors.lastname: Montero Rodríguez
authors.forename: A
authors.initials: A
authors.lastname: Julve San Martín
authors.forename: A
authors.initials: A
authors.lastname: Gálvez Ruiz
authors.forename: E
authors.initials: E
authors.lastname: Mencía Gutiérrez
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002387:Cataract Extraction / Q000009:adverse effects; D015897:Comorbidity; D003228:Conjunctiva / Q000473:pathology; D003229:Conjunctival Diseases / Q000453:epidemiology* / Q000209:etiology; D003560:Cysts / Q000453:epidemiology* / Q000209:etiology; D005205:Fascia / Q000473:pathology; D000071938:Fasciotomy; D005260:Female; D005901:Glaucoma / Q000453:epidemiology / Q000601:surgery*; D020327:Glaucoma Drainage Implants / Q000009:adverse effects; D005932:Gloves, Surgical; D006801:Humans; D015994:Incidence; D053685:Laser Therapy / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000453:epidemiology / Q000209:etiology; D011183:Postoperative Complications / Q000453:epidemiology* / Q000209:etiology; D011208:Powders; D011446:Prospective Studies; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology; D013213:Starch / Q000009:adverse effects; D014130:Trabeculectomy / Q000009:adverse effects; D017211:Treatment Failure
chemical_list: D011208:Powders; D013213:Starch